Bloomberg Law
Sept. 30, 2019, 9:36 PM

Bracco Gets Second Chance in Jubilant Case Over Imaging Agent

Susan Decker
Susan Decker
Bloomberg News

The U.S. International Trade Commission said it will review a judge’s findings that deemed invalid three Bracco patents for a radioisotope infusion system used in heart-imaging procedures, the agency said in a notice posted on its website.

  • Bracco claims Jubilant Life Sciences’s Ruby imaging agent infringes three patents for strontium-rubidium radioisotope infusion systems.
  • Bracco is seeking an order to block imports of Jubilant DraxImage systems made in Canada.
  • Patents cover a computer-controlled medical device, plus the method of making it and ways to use it to infuse a patient with radioisotope rubidium-82 during an imaging process.
  • Several nuclear medicine technologists ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.